Atlas Trials

Point-of-care Measurement of the Antifibrinolytic Activity of Tranexamic Acid in Cardiac Surgery

Clinical trial NCT06128330 · RECRUITING

Trial details

NCT number
NCT06128330
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Antifibrinolytic Agents
Start date
2023-12-15
Primary completion
2025-12-31
Enrollment
322

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.